1ROSES A D. Pharmacogenetics and drug development: the path to safer and more effective drugs [ J ]. Nat Rev Genet, 2004, 5 ( 9 ) : 645 - 656.
2GOLDSTEIN D B, TATE S K. SISODIYA S M. Pharmacogenetics goes genomic[J].Nat Rev Genet, 2003, 4 (12) : 937 -947.
3COHEN J C. Contribution of cholesterol poprotein metabolism [ J]. Curr Opin Lipidol, 1999,10(4 ) :303 - 307.
4KAJINAMI K, BROUSSEAU M E, ORDOVAS J M, et al. CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypereholesterolemia[J]. Am J Cardiol, 2004, 93 (1): 104-107.
5KIRCHHEINER J, KUDLICZ D, MEISEL C, et al. Influence of CYP2C9 polymorphlsms on the pharmacokinetics and cholesterollowering activity of ( - ) 23S, 5R2fluvastatin and ( + ) 23R, 5S-fluvastatin in healthy volunteers [ J ]. Clin Pharmcol Ther, 2003,74 (2) :186 -194.
6MULDERA B, VAN LIJF H J, BON M A M,et al. Association of polymorphisrn in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin [ J ]. Clin Pharmacol Ther, 2001,70 ( 6 ) : 546 - 551.
7NISHIZATO Y, IEIRI I, SUZUKI H, et al. Polymorphisms of OATPC( SLC21A6 ) and OA33 ( SLC22A8 ) genes: consequences for pravastatin pharmacokinetics [ J ]. Clin Pharmacol Ther, 2003, 73 (6) : 554-565.
8NIEMIM, SCHAEFFELER E, LANG T, et al. High plasma p ravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C( OATP-C, SLCOI B1 ) [ J]. Pharmacogenetics, 2004, 14 (7) : 429 -440.
9CHASMAN D I, POSADA D, SUBRAHMANYAN L, et al.Pharmacogenetic study of statin therapy and cholesterol reduction [J].JAMA, 2006,291 (23) : 2821 -2827.
10ORSOVAS J M,VARGAS C,SANTOS A, et al. The G/A promoter polymorphism at the apoAI gene locus predics individual variability in fasting and postprandial responses to the HMG-CoA reductase inhibitor atorvastatin [ J ]. Circulation,2005,100 ( suppl I) : 1 - 239.
10Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：345
